11 March 2025 The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another ...

22 October 2025 Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how ...

East IP, in the ‘Highly Recommended’ category, handles trademark work in China for Ticketmaster’s parent company Live Nation ...

Parties impacted by exclusion orders need to carefully weigh their options for seeking clarity or rulings on redesigns, ...

As IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks in life sciences ...

25 September 2025 A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting ...

Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year. If you ...

Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most ...

A US appeals court had good news for the California-based medtech company in a dispute over its Sapien 3 Ultra transcatheter heart valve.

The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment. If you don't ...

LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California. LSIPR’s fifth annual LSPN North America Fall conference returns to San ...

Latest News & FeaturesAs IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks in life sciences deals aren’t always in the patents—they’re in the ...